Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis.
- Resource Type
- Article
- Source
- Inflammatory Bowel Diseases; Oct2023, Vol. 29 Issue 10, p1633-1647, 15p
- Subject
- Language
- ISSN
- 10780998